Raihan Ruksana, Azzeri Amirah, H Shabaruddin Fatiha, Mohamed Rosmawati
Department of Microbiology, Faculty of Medicine, AIMST University, Kedah, Malaysia.
Department of Social and Preventive Medicine Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Euroasian J Hepatogastroenterol. 2018 Jan-Jun;8(1):54-56. doi: 10.5005/jp-journals-10018-1259. Epub 2018 May 1.
Hepatocellular carcinoma (HCC) is one of the leading causes of death globally. In Malaysia liver cancer is the eighth most common cause of cancer for both gender and fifth most common cause of cancer for males. Liver cancer is a cause of premature death in Malaysia: The trend from 1990 to 2010 was observed upward. Since 1990, the annual years of life lost (YLLs) from liver cancer have increased by 31.5%. Older persons are at higher risk and there is male predominance observed. Curative surgical resection, liver transplantation, and supportive symptomatic care, including percutaneous ethanol injection and radiofrequency ablation (RFA), and noncurative transarterial chemoembolization (TACE) are among available treatment facilities. Yet the survival rate is very poor as majority of patients present at very advanced stage. Hepatitis B virus (HBV) remained the leading cause of HCC in Malaysia. Several studies showed cryptogenic causes, which are mainly nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) among the predominant causes of HCC in Malaysia than hepatitis C virus (HCV), alcohol, or any other reason. This mainly correlates with the increasing incidence of diabetes and obesity in Malaysia. Raihan R, Azzeri A, Shabaruddin FH, Mohamed R. Hepatocellular Carcinoma in Malaysia and Its Changing Trend. Euroasian J Hepato-Gastroenterol 2018;8(1):54-56.
肝细胞癌(HCC)是全球主要的死亡原因之一。在马来西亚,肝癌是男女第八大常见癌症病因,也是男性第五大常见癌症病因。肝癌是马来西亚过早死亡的一个原因:1990年至2010年呈上升趋势。自1990年以来,肝癌导致的年度生命损失年数(YLLs)增加了31.5%。老年人风险更高,且观察到男性占主导。根治性手术切除、肝移植以及支持性对症治疗,包括经皮乙醇注射和射频消融(RFA),以及非根治性经动脉化疗栓塞(TACE)都是可用的治疗手段。然而,由于大多数患者就诊时已处于非常晚期,生存率非常低。乙型肝炎病毒(HBV)仍然是马来西亚肝癌的主要病因。几项研究表明,在马来西亚,隐匿性病因主要是非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH),它们是肝癌比丙型肝炎病毒(HCV)、酒精或任何其他原因更主要的病因。这主要与马来西亚糖尿病和肥胖发病率的上升有关。Raihan R、Azzeri A、Shabaruddin FH、Mohamed R。马来西亚的肝细胞癌及其变化趋势。《欧亚肝脏胃肠病学杂志》2018年;8(1):54 - 56。